小分子药物重定位用于肾单位肾痨及相关肾纤毛病
肾单位肾痨是儿童和青年肾衰竭最常见的遗传性肾小管间质肾病,目前无治愈性治疗。本综述总结了基于疾病机制的药物重定位策略,包括靶向已识别信号通路的小分子及基于细胞的表型筛选,这些化合物在同源小鼠模型中显示出对肾脏和/或肾外缺陷的有益作用。
要点
- 肾单位肾痨是儿童和青年肾衰竭最常见的遗传性病因,目前无治愈性治疗。
- 针对已识别信号通路的小分子在同源小鼠模型中显示出有益作用。
- 基于细胞的表型筛选可识别能挽救纤毛发生缺陷的小分子。
核心结论
- 本综述总结了肾单位肾痨相关纤毛病中药物重定位策略的研究,强调利用靶向通路的小分子和表型筛选化合物在临床前模型中的有益作用。
研究设计与样本
- 综述类文章,检索范围聚焦于肾单位肾痨及相关肾纤毛病中已报道的小分子药物重定位研究。
主要发现
- 针对已识别信号通路的小分子在同源小鼠模型中显示出有益作用。
- 基于细胞的表型筛选可识别能挽救肾单位肾痨条件下纤毛发生缺陷的小分子。
- 这些化合物在测试时显示出对肾单位肾痨相关肾脏和/或肾外缺陷的有益作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nephronophthisis is an autosomal recessive tubulointerstitial nephropathy, belonging to the ciliopathy disorders, characterized by fibrosis and/or cysts. It is the most common genetic cause of kidney failure in children and young adults. Clinically and genetically heterogeneous, it is caused by variants in ciliary genes, resulting in either an isolated kidney disease or syndromic forms in association with other manifestations of ciliopathy disorders. No curative treatment is currently available. Over the past 2 decades, advances in understanding disease mechanisms have identified several dysregulated signaling pathways, some shared with other cystic kidney diseases. Notably, molecules previously developed to target these pathways have shown promising beneficial effects in orthologous mouse models. In addition to these knowledge-based repurposing approaches, unbiased "in cellulo" phenotypic screens of "repurposing" libraries identified small molecules able to rescue the ciliogenesis defects observed in nephronophthisis conditions. Those compounds appeared to act on relevant pathways and, when tested, showed beneficial nephronophthisis-associated kidney and/or extrarenal defects in mice. In this review, we have summarized those studies that highlight the drug repurposing strategies in the context of a rare disorders, such as nephronophthisis-related ciliopathies, with broad genetic heterogeneity and systemic manifestations but with shared disease mechanisms.
引用
- Benmerah A, Briseño-Roa L, Annereau JP, et al. Repurposing small molecules for nephronophthisis and related renal ciliopathies. Kidney Int. 2023. PMID: 37244473. doi:10.1016/j.kint.2023.04.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。